BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Q, Shen ZF, Wu BS, Xu CB, He ZQ, Chen T, Shang HT, Xie CF, Huang SY, Chen YG, Chen HB, Han ST. Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2019;2019:5363261. [PMID: 31781191 DOI: 10.1155/2019/5363261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 D'Antongiovanni V, Fornai M, Pellegrini C, Benvenuti L, Blandizzi C, Antonioli L. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. Int J Mol Sci 2020;21:E5089. [PMID: 32708507 DOI: 10.3390/ijms21145089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, Wu K, Cao Y, Ng K, Ogino S. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol 2021;18:230-43. [PMID: 33219329 DOI: 10.1038/s41571-020-00445-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 8.5] [Reference Citation Analysis]
3 Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E. Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies. Nutrients 2020;12:E1339. [PMID: 32397163 DOI: 10.3390/nu12051339] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Tang ML, Li H, Ning JF, Shen X, Sun X. Discovery of First-in-Class TAK1-MKK3 Protein-Protein Interaction (PPI) Inhibitor (R)-STU104 for the Treatment of Ulcerative Colitis through Modulating TNF-α Production. J Med Chem 2022. [PMID: 35442672 DOI: 10.1021/acs.jmedchem.1c02198] [Reference Citation Analysis]
5 Murthy SK, Feuerstein JD, Nguyen GC, Velayos FS. AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology 2021;161:1043-1051.e4. [PMID: 34416977 DOI: 10.1053/j.gastro.2021.05.063] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yadav A, Jena A, Arpitha K, Shah J, Vaiphei K, Dutta U, Singh AK. Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease. Inflamm Bowel Dis 2022:izac033. [PMID: 35230448 DOI: 10.1093/ibd/izac033] [Reference Citation Analysis]
7 Bai Y, Wang G, Lan J, Wu P, Liang G, Huang J, Wu Z, Wang Y, Chen C, Touboul D. Mass Spectrometric Behavior and Molecular Mechanisms of Fermented Deoxyanthocyanidins to Alleviate Ulcerative Colitis Based on Network Pharmacology. International Journal of Analytical Chemistry 2022;2022:1-12. [DOI: 10.1155/2022/9293208] [Reference Citation Analysis]
8 Ma R, Yuan D, Guo Y, Yan R, Li K. Immune Effects of γδ T Cells in Colorectal Cancer: A Review. Front Immunol 2020;11:1600. [PMID: 33013819 DOI: 10.3389/fimmu.2020.01600] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Majumder S, Shivaji UN, Kasturi R, Sigamani A, Ghosh S, Iacucci M. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives. World J Gastrointest Oncol 2022; 14(3): 547-567 [DOI: 10.4251/wjgo.v14.i3.547] [Reference Citation Analysis]
10 Rabbenou W, Ullman TA. Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:791-807. [PMID: 33121696 DOI: 10.1016/j.gtc.2020.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Loke YL, Chew MT, Ngeow YF, Lim WWD, Peh SC. Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota. Front Cell Infect Microbiol 2020;10:603086. [PMID: 33364203 DOI: 10.3389/fcimb.2020.603086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Yalchin M, Baker AM, Graham TA, Hart A. Predicting Colorectal Cancer Occurrence in IBD. Cancers (Basel) 2021;13:2908. [PMID: 34200768 DOI: 10.3390/cancers13122908] [Reference Citation Analysis]
13 Creff J, Malaquin L, Besson A. In vitro models of intestinal epithelium: Toward bioengineered systems. J Tissue Eng 2021;12:2041731420985202. [PMID: 34104387 DOI: 10.1177/2041731420985202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhao Q, Guo J, Wang G, Bi Y, Cheng X, Liao Y, Jin S, Li L, Guo Y, Pan L, Zhang X, Tan Y, Zhou G, Yu X. CXCL13 promotes intestinal tumorigenesis through the activation of epithelial AKT signaling. Cancer Lett 2021;511:1-14. [PMID: 33894331 DOI: 10.1016/j.canlet.2021.04.012] [Reference Citation Analysis]
15 Sakai K, De Velasco MA, Kura Y, Nishio K. Transcriptome Profiling and Metagenomic Analysis Help to Elucidate Interactions in an Inflammation-Associated Cancer Mouse Model. Cancers (Basel) 2021;13:3683. [PMID: 34359585 DOI: 10.3390/cancers13153683] [Reference Citation Analysis]
16 Ge Y, Pan M, Zhang C, Wang C, Ma K, Yan G, Wang T, Wu D, Shao J. Paeonol alleviates dextran sodium sulfate induced colitis involving Candida albicans-associated dysbiosis. Med Mycol 2021;59:335-44. [PMID: 32598443 DOI: 10.1093/mmy/myaa053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Qian K, Yuan L, Wang S, Kuang Y, Jin Q, Long D, Jiang Y, Zhao H, Liu K, Yao H. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling. Clin Exp Immunol 2021;205:246-56. [PMID: 33942299 DOI: 10.1111/cei.13613] [Reference Citation Analysis]